Yep, at the end of the day it’s a much needed update.Summary: Waiting for assays re Kanuka, and the reason we haven’t heard anything re Kitotolo is because we have only just started there...That’s all I was after (for now), a simple update
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025